Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
Gross Profit
Creo Medical Group PLC
Gross Profit Peer Comparison
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Creo Medical Group PLC
LSE:CREO
|
Gross Profit
£13.1m
|
CAGR 3-Years
1 284%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Gross Profit
$3.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Gross Profit
$804.6m
|
CAGR 3-Years
11%
|
CAGR 5-Years
2%
|
CAGR 10-Years
12%
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Gross Profit
$61m
|
CAGR 3-Years
91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Gross Profit
£24.4m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
1%
|
CAGR 10-Years
4%
|
|
Angle PLC
LSE:AGL
|
Gross Profit
£1.1m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Gross Profit?
Gross Profit
13.1m
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Gross Profit amounts to 13.1m GBP.
What is Creo Medical Group PLC's Gross Profit growth rate?
Gross Profit CAGR 3Y
1 284%
Over the last year, the Gross Profit growth was 13%. The average annual Gross Profit growth rates for Creo Medical Group PLC have been 1 284% over the past three years .